Charles River Laboratories
302 hedge funds and large institutions have $4.65B invested in Charles River Laboratories in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 128 increasing their positions, 106 reducing their positions, and 30 closing their positions.
237% more call options, than puts
Call options by funds: $7.74M | Put options by funds: $2.3M
21% more repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 106
11% more capital invested
Capital invested by funds: $4.2B → $4.65B (+$448M)
10% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 30
1% more funds holding
Funds holding: 300 → 302 (+2)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2.16% less ownership
Funds ownership: 98.67% → 96.51% (-2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$60M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$54.4M |
| 3 |
Morgan Stanley
New York
|
+$31M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$29.4M |
| 5 |
Millennium Management
New York
|
+$19.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$72.6M |
| 2 |
Primecap Management
Pasadena,
California
|
-$38.8M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$37.2M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$30.2M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$18.7M |
CRL Hedge Fund Activity: Q2 2017 in Review
302 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2017, worth a combined $4.65B — up 11% from $4.2B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new CRL positions and 30 closed out — a net gain of 3 holders — while 128 added to existing stakes and 106 trimmed.
The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $60M. The largest seller was Wellington Management Group, exiting entirely with an estimated $72.6M sold.
- 302 institutional investors held Charles River Laboratories (CRL) as of Q2 2017, up from 300 in Q1 2017.
- Funds reported $4.65B of Charles River Laboratories stock for Q2 2017, up 11% quarter-over-quarter.
- 33 funds opened new Charles River Laboratories positions in Q2 2017 and 30 closed out, a net change of +3 holders.
- The largest Charles River Laboratories buyer in Q2 2017 was Lord, Abbett & Co, an estimated $60M added.
- The largest Charles River Laboratories seller in Q2 2017 was Wellington Management Group, an estimated $72.6M sold.
Based on aggregated 13F filings for Q2 2017.